Clinical trial Recruiting at 2 sites Interventional Ages 40 to 65

Scapular and upper-arm PNF techniques for stroke-related scapular dyskinesia

Official title: Effects of Scapular and Upper Limb Proprioceptive Neuromuscular Facilitation Techniques on Shoulder Pain, Upper Limb Function & Gait in Stroke With Scapular Dyskinesia.

Run by Riphah International University · NCT07148466 · Data updated 2026-11-12

This trial will test whether adding scapular and upper-limb PNF exercises to usual physiotherapy helps people aged 40–65 with subacute stroke and scapular dyskinesia reduce shoulder pain and improve arm function and walking.

Quick facts

Study typeInterventional
Ages40 Years to 65 Years
SexAll
Enrollment44 (estimated)
SponsorRiphah International University
Academic / other
Locations2 sites (Islamabad, Punjab Province and 1 other locations)
StatusRecruiting
StartedAugust 19, 2025
Main results expectedJanuary 20, 2026
Study endsFebruary 21, 2026
Registry record updatedAugust 29, 2025
Trial IDNCT07148466 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 40–65 with subacute MCA stroke who have scapular dyskinesia, mild spasticity (MAS around +1 to 1), and impaired gait (DGI < 19).

Probably not a fit

Patients with other neurological disorders, major medical or psychiatric conditions, inability to follow instructions, or those outside the age/gait/spasticity criteria are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial enrolls 44 people with subacute middle cerebral artery stroke and scapular dyskinesia, randomly assigning them to either conventional physiotherapy alone or conventional physiotherapy plus scapular and upper-limb proprioceptive neuromuscular facilitation (PNF). The experimental group receives scapular PNF coupled with upper-limb PNF patterns aimed at improving scapular kinematics and neuromuscular control in addition to standard care. Primary outcomes include shoulder pain, upper-limb function, and gait performance, measured before and after the intervention period. Study sites are HBS Hospital and the National Institute of Rehabilitation Medicine in Islamabad, Pakistan.

Why it matters

Potential benefit: If successful, adding scapular and upper-limb PNF to standard physiotherapy could reduce shoulder pain and improve arm function and walking in people after stroke.

How similar studies have gone: PNF techniques have shown benefit for motor control and shoulder function in stroke and musculoskeletal conditions, but targeted scapular PNF for post-stroke scapular dyskinesia is relatively novel and evidence is limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* • Sub-acute

  * MCA
  * Age bracket 40-65 years.
  * Gender Male or Female.
  * Gait baseline score (DGI less than 19)
  * Patients with spasticity between grades (+1 and 1) on the Modified Ashworth Scale (MAS).

Exclusion Criteria:

* • Inability to communicate/understand instructions.

  * Stroke with other neurological conditions.
  * Patient with any other psychological and medical condition.

Where it's running

  • HBS Hospital islamabad
    Islamabad, Punjab Province, Pakistan
    Recruiting
  • National institute of rehablitation medicine islamabad
    Islamabad, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.